• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Metab Res Rev . The association of obesity with the progression and outcome of COVID-19: the insight from an artificial intelligence (AI) -

tetano

Editor, Senior Moderator
Diabetes Metab Res Rev


. 2022 Jan 21;e3519.
doi: 10.1002/dmrr.3519. Online ahead of print.
The association of obesity with the progression and outcome of COVID-19: the insight from an artificial intelligence (AI) - based imaging quantitative analysis on computed tomography


Xiaoting Lu[SUP] 1 2 [/SUP], Zhenhai Cui[SUP] 3 4 [/SUP], Xiang Ma[SUP] 1 2 [/SUP], Feng Pan[SUP] 1 2 [/SUP], Lingli Li[SUP] 1 2 [/SUP], Jiazheng Wang[SUP] 5 [/SUP], Peng Sun[SUP] 6 [/SUP], Huiqing Li[SUP] 3 4 [/SUP], Lian Yang[SUP] 1 2 [/SUP], Bo Liang[SUP] 1 2 [/SUP]



Affiliations

Abstract

Aim: To explore the association of obesity with the progression and outcome of coronavirus disease 2019 (COVID-19) at the acute period and 5-month follow-up from the perspectives of computed tomography (CT) imaging with artificial intelligence (AI) - based quantitative evaluation, which may help to predict the risk of obese COVID-19 patients progressing to severe and critical disease.
Materials and methods: This retrospective cohort enrolled 213 hospitalized COVID-19 patients. Patients were classified into three groups according to their body mass index (BMI): normal weight (from 18.5 to < 24 kg/m[SUP]2[/SUP] ), overweight (from 24 to < 28 kg/m[SUP]2[/SUP] ), and obesity (≥ 28 kg/m[SUP]2[/SUP] ).
Results: Compared with normal weight patients, patients with higher BMI were associated with more lung involvements in lung CT examination [lung lesions volume (cm[SUP]3[/SUP] ), normal weight vs overweight vs obesity; 175.5(34.0-414.9) vs 261.7(73.3-576.2) vs 395.8(101.6-1135.6); P = .002], and were more inclined to deterioration at the acute period. At the 5-month follow-up, the lung residual lesion was more serious [residual total lung lesions volume (cm[SUP]3[/SUP] ), normal weight vs overweight vs obesity; 4.8(0.0-27.4) vs 10.7(0.0-55.5) vs 30.1(9.5-91.1); P = .015] and the absorption rates were lower for higher BMI patients [absorption rates of total lung lesions volume (%), normal weight vs overweight vs obesity; 99.6(94.0-100.0) vs 98.9(85.2-100.0) vs 88.5(66.5-95.2); P = .013]. The clinical-plus-AI parameter model was superior to the clinical-only parameter model in the prediction of disease deterioration [AUC (areas under the ROC curve), 0.884 vs 0.794, P < .05].
Conclusions: Obesity was associated with severe pneumonia lesions on CT and adverse clinical outcomes. The AI-based model with combinational use of clinical and CT parameters had incremental prognostic value over the clinical parameters alone. This article is protected by copyright. All rights reserved.

Keywords: AI; COVID-19; CT; obesity; prognosis.
 
Back
Top Bottom